VisasQ will exhibit at BioJapan 2026 (7–9 October, Yokohama). At the exhibition, the company will introduce VisasQ interview and explain how primary information can be used to accelerate application discovery and validation of target needs.
VisasQ will exhibit at BioJapan 2026, held at Pacifico Yokohama from 7 to 9 October 2026. The company will exhibit at booth D-112 and introduce the background to its participation and the use of its knowledge platform.
As the background to its participation, the company cites its use of a database of insights from more than 800,000 people in Japan and overseas to support the implementation of innovations in society, not only in drug discovery and regenerative medicine but also in areas such as biomaterials and food tech. While accelerating R&D and commercialisation, it emphasises the importance of obtaining primary information.
The exhibition will focus on VisasQ interview, highlighting three features: the ability to conduct one-hour interviews with experts in 190 countries and regions worldwide and obtain the primary information required; access to on-the-ground information not found in the literature; and dedicated staff who propose appropriate experts.
The company will also provide examples of the service, illustrate how it can be used and direct visitors to the enquiry page. Information on the company and its stock market performance will also be provided.